Benoît Misset

Prof. Benoît Misset


Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2001 in JAMA
Verified
Journal Article
Closed access
PDF file
JMJacques Merrer
Jacques Merrer
BJBernard De Jonghe
Bernard De Jonghe
FGFranck Golliot
Franck Golliot
JLJean-Yves Lefrant
Jean-Yves Lefrant
BRBrigitte Raffy
Brigitte Raffy
GNGérard Nitenberg
Gérard Nitenberg
Research from JAMA — Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients — A Randomized Controlled Trial — ContextWhether venous catheterization at the femoral site is associated with an increased risk of complications compared with that at the subclavian site is debated.ObjectiveTo compare mechanical, infectious, and thrombotic complications of femoral and subclavian venous catheterization.Design and SettingConcealed, randomized controlled clinical trial conducted between December 1997 and July 2000 at 8 intensive care units (ICUs) in France.PatientsTwo hundred eighty-nine adult patients receiving a first central venous catheter.InterventionsPatients were randomly assigned to undergo central venous catheterization at the femoral site (n = 145) or subclavian site (n = 144).Main Outcome MeasuresRate and severity of mechanical, infectious, and thrombotic complications, compared by catheterization site in 289, 270, and 223 patients, respectively.ResultsFemoral catheterization was associated with a higher incidence rate of overall infectious complications (19.8% vs 4.5%; P<.001; incidence density of 20 vs 3.7 per 1000 catheter-days) and of major infectious complications (clinical sepsis with or without bloodstream infection, 4.4% vs 1.5%; P = .07; incidence density of 4.5 vs 1.2 per 1000 catheter-days), as well as of overall thrombotic complications (21.5% vs 1.9%; P<.001) and complete thrombosis of the vessel (6% vs 0%; P = .01); rates of overall and major mechanical complications were similar between the 2 groups (17.3% vs 18.8 %; P = .74 and 1.4% vs 2.8%; P = .44, respectively). Risk factors for mechanical complications were duration of insertion (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.03-1.08 per additional minute; P<.001); insertion in 2 of the centers (OR, 4.52; 95% CI, 1.81-11.23; P = .001); and insertion during the night (OR, 2.06; 95% CI, 1.04-4.08; P = .03). The only factor associated with infectious complications was femoral catheterization (hazard ratio [HR], 4.83; 95% CI, 1.96-11.93; P<.001); antibiotic administration via the catheter decreased risk of infectious complications (HR, 0.41; 95% CI, 0.18-0.93; P = .03). Femoral catheterization was the only risk factor for thrombotic complications (OR, 14.42; 95% CI, 3.33-62.57; P<.001).ConclusionFemoral venous catheterization is associated with a greater risk of infectious and thrombotic complications than subclavian catheterization in ICU patients.

1 March 2018 in New England Journal of Medicine
Verified
Journal Article
Closed access
DAdjillali Annane
djillali Annane
ARAlain Renault
Alain Renault
CBChristian Brun-Buisson
Christian Brun-Buisson
Bruno MégarbaneBruno Mégarbane
Bruno Mégarbane
JQJean-Pierre Quenot
Jean-Pierre Quenot
EBEric Bellissant
Eric Bellissant
Septic shock is characterized by dysregulation of the host response to infection, with circulatory, cellular, and metabolic abnormalities. We hypothesized that therapy with hydrocortisone plus fludrocortisone or with drotrecogin alfa (activated), which can modulate the host response, would improve the clinical outcomes of patients with septic shock.

1 November 1991 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CMC Munoz
C Munoz
JCJ Carlet
J Carlet
CFC Fitting
C Fitting
BMBenoît Misset
Benoît Misset
JBJ P Blériot
J P Blériot
JCJ M Cavaillon
J M Cavaillon
The production by monocytes of interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF alpha) in intensive care unit (ICU) patients with sepsis syndrome (n = 23) or noninfectious shock (n = 6) is reported. Plasma cytokines, cell-associated cytokines within freshly isolated monocytes and LPS-induced in vitro cytokine production were assessed at admission and at regular intervals during ICU stay. TNF alpha and IL-6 were the most frequently detected circulating cytokines. Despite the fact that IL-1 alpha is the main cytokine found within monocytes upon in vitro activation of cells from healthy individuals, it was very rarely detected within freshly isolated monocytes from septic patients, and levels of cell-associated IL-1 beta were lower than those of TNF alpha. Cell-associated IL-1 beta and TNF alpha were not correlated with corresponding levels in plasma. Upon LPS stimulation, we observed a profound decrease of in vitro IL-1 alpha production by monocytes in all patients, and of IL-1 beta, IL-6, and TNF alpha in septic patients. This reduced LPS-induced production of cytokines was most pronounced in patients with gram-negative infections. Finally, monocytes from survival patients, but not from nonsurvival ones recovered their capacity to produce normal amounts of cytokines upon LPS stimulation. In conclusion, our data indicate an in vivo activation of circulating monocytes during sepsis as well as in noninfectious shock and suggest that complex regulatory mechanisms can downregulate the production of cytokines by monocytes during severe infections.

1 July 2012 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
SBStijn Blot
Stijn Blot
FTFabio Silvio Taccone
Fabio Silvio Taccone
AAAnne-Marie Van Den Abeele
Anne-Marie Van Den Abeele
PBPierre Bulpa
Pierre Bulpa
WMWouter Meersseman
Wouter Meersseman
DVDirk Vogelaers
Dirk Vogelaers
Rationale: The clinical relevance of Aspergillus-positive endotracheal aspirates in critically ill patients is difficult to assess. Objectives: We externally validate a clinical algorithm to discriminate Aspergillus colonization from putative invasive pulmonary aspergillosis in this patient group. Methods: We performed a multicenter (n = 30) observational study including critically ill patients with one or more Aspergillus-positive endotracheal aspirate cultures (n = 524). The diagnostic accuracy of this algorithm was evaluated using 115 patients with histopathologic data, considered the gold standard. Subsequently, the diagnostic workout of the algorithm was compared on the total cohort (n = 524), with the categorization based on the diagnostic criteria of the European Organization for the Research and Treatment of Cancer/Mycoses Study Group. Measurements and Main Results: Among 115 histopathology-controlled patients, 79 had proven aspergillosis. The algorithm judged 86 of 115 cases to have putative aspergillosis. This diagnosis was confirmed in 72 and rejected in 14 patients. The algorithm judged 29 patients to have Aspergillus colonization. This was confirmed in 22 and rejected in 7 patients. The algorithm had a specificity of 61% and a sensitivity of 92%. The positive and negative predictive values were 61 and 92%, respectively. In the total cohort (n = 524), 79 patients had proven invasive pulmonary aspergillosis (15.1%). According to the European Organization for the Research and Treatment of Cancer/Mycoses Study Group criteria, 32 patients had probable aspergillosis (6.1%) and 413 patients were not classifiable (78.8%). The algorithm judged 199 patients to have putative aspergillosis (38.0%) and 246 to have Aspergillus colonization (46.9%). Conclusions: The algorithm demonstrated favorable operating characteristics to discriminate Aspergillus respiratory tract colonization from invasive pulmonary aspergillosis in critically ill patients.

1 January 2018 in The Lancet
Verified
Journal Article
Closed access
JRJean Reignier
Jean Reignier
JBJulie Boisrame-Helms
Julie Boisrame-Helms
LBLaurent Brisard
Laurent Brisard
JLJean-Baptiste Lascarrou
Jean-Baptiste Lascarrou
AHAli Ait Hssain
Ali Ait Hssain
LBLaetitia Bodet-Contentin
Laetitia Bodet-Contentin

12 January 2015 in Critical Care
Verified
Journal Article
Open access
PDF file
Fabio Silvio TacconeFabio Silvio Taccone
Fabio Silvio Taccone
AAAnne-Marie V. Van den Abeele
Anne-Marie V. Van den Abeele
PBPierre Bulpa
Pierre Bulpa
BMBenoît Misset
Benoît Misset
WMWouter Meersseman
Wouter Meersseman
OIon behalf of the AspICU Study Investigators
on behalf of the AspICU Study Investigators
Introduction: Invasive aspergillosis (IA) is a fungal infection that particularly affects immunocompromised hosts. Recently, several studies have indicated a high incidence of IA in intensive care unit (ICU) patients. However, few data are available on the epidemiology and outcome of patients with IA in this setting. Methods: An observational study including all patients with a positive Aspergillus culture during ICU stay was performed in 30 ICUs in 8 countries. Cases were classified as proven IA, putative IA or Aspergillus colonization according to recently validated criteria. Demographic, microbiologic and diagnostic data were collected. Outcome was recorded 12 weeks after Aspergillus isolation. Results: A total of 563 patients were included, of whom 266 were colonized (47%), 203 had putative IA (36%) and 94 had proven IA (17%). The lung was the most frequent site of infection (94%), and Aspergillus fumigatus the most commonly isolated species (92%). Patients with IA had higher incidences of cancer and organ transplantation than those with colonization. Compared with other patients, they were more frequently diagnosed with sepsis on ICU admission and more frequently received vasopressors and renal replacement therapy (RRT) during the ICU stay. Mortality was 38% among colonized patients, 67% in those with putative IA and 79% in those with proven IA (P < 0.001). Independent risk factors for death among patients with IA included older age, history of bone marrow transplantation, and mechanical ventilation, RRT and higher Sequential Organ Failure Assessment score at diagnosis. Conclusions: IA among critically ill patients is associated with high mortality. Patients diagnosed with proven or putative IA had greater severity of illness and more frequently needed organ support than those with Aspergillus spp colonization.